Precision Health Reports Market Research Report

Company Overview

• Name: Precision Health Reports, Inc.

• Mission of the Company: To provide healthcare providers with tools that allow them to address individual cardiometabolic risks earlier in the disease cycle, enable the prevention of progression to costly and deadly conditions such as diabetes, heart attack, or stroke.

• Founded: April 2020

• Founders: Matthew Martin (CEO) and Dr. William Cromwell, MD, FAHA, FNLA, FAAFP (Chief Medical Officer)

• Key People:

• Matthew Martin - Chief Executive Officer

• Dr. William Cromwell, MD - Chief Medical Officer

• Headquarters: No information is available

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Providing actionable and comprehensive cardiometabolic risk assessments that power shared decision-making for individual health management.

Products

Cardiometabolic Risk Assessment

• Description: This comprehensive diagnostic tool integrates patient-specific clinical data, outcome-proven biomarkers, and clinical guidelines to assess individual risk for developing diseases such as metabolic syndrome, type 2 diabetes, or atherosclerotic cardiovascular disease (ASCVD) events (e.g., stroke, heart attack).

• Key Features:

• Incorporates over 40 risk factors from various guidelines (ACC, ESC, NLA, AACE, ADA, MESA).

• Includes individual medical history and longitudinal tracking.

• Identifies critical factors that amplify the risk and tracks biomarkers predictive of risk reduction.

Diabetic Risk Assessment

• Description: This analysis evaluates an individual's risk of developing type 2 diabetes, offering more comprehensive insights than simply monitoring blood glucose levels.

• Key Features:

• Utilizes outcome-proven biomarkers for accurate risk identification.

• Allows monitoring of factors predictive of individual response to interventions.

Recent Developments

• Product Enhancements (August 8, 2023):

• Released significant updates to the Cardiometabolic Risk Assessment product to harmonize with guidelines from medical associations like ACC and ESC.

• Introduced new "threshold goals" for lipid/lipoprotein values, emphasizing personalized health optimization and shared decision-making between patients and providers.

• Partnerships (March 21, 2023):

• Partnered with Curative Inc. to provide Curative members with a cardiometabolic risk evaluation, enhancing shared decision-making and supporting healthier individual outcomes.

• Product Launch (March 17, 2021):

• Launched the Cardiometabolic Risk Assessment to aid in efficient risk assessment and management of heart attack, stroke, and diabetes risk.

• Awards and Recognition:

• Precision Health Reports was among the finalists for the 2020 NC IDEA SEED Grant, demonstrating innovation in identifying and managing cardiometabolic risks.

This structured overview of Precision Health Reports details their focus on early individual cardiometabolic disease assessment and management. While no information is provided on revenue or employee numbers, the company's emphasis on personalized healthcare tools illustrates their commitment to improving health outcomes through advanced diagnostic solutions.